Hirofumi Kawamata

420 total citations
32 papers, 302 citations indexed

About

Hirofumi Kawamata is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hirofumi Kawamata has authored 32 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 17 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hirofumi Kawamata's work include Lipoproteins and Cardiovascular Health (9 papers), Cardiac Imaging and Diagnostics (6 papers) and Coronary Interventions and Diagnostics (6 papers). Hirofumi Kawamata is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Cardiac Imaging and Diagnostics (6 papers) and Coronary Interventions and Diagnostics (6 papers). Hirofumi Kawamata collaborates with scholars based in Japan, Italy and Germany. Hirofumi Kawamata's co-authors include Shigemasa Tani, Ken Nagao, Takeo Anazawa, Atsushi Hirayama, Kiyoshi Iida, Michiaki Matsumoto, Hiroshi Takahashi, Yuichi Sato, Toshio Kushiro and Eizo Tachibana and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Cardiology and Atherosclerosis.

In The Last Decade

Hirofumi Kawamata

26 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirofumi Kawamata Japan 10 159 118 81 68 52 32 302
Michiaki Matsumoto Japan 12 133 0.8× 104 0.9× 47 0.6× 72 1.1× 58 1.1× 26 292
Takeo Anazawa Japan 13 185 1.2× 138 1.2× 123 1.5× 82 1.2× 61 1.2× 23 401
Sida Jia China 11 141 0.9× 202 1.7× 46 0.6× 97 1.4× 56 1.1× 35 372
Lin Jiang China 12 123 0.8× 198 1.7× 70 0.9× 36 0.5× 45 0.9× 42 370
E. de Groot Netherlands 7 141 0.9× 203 1.7× 58 0.7× 85 1.3× 40 0.8× 14 363
Shigeru Matsui Japan 10 111 0.7× 188 1.6× 77 1.0× 33 0.5× 35 0.7× 19 419
Dorota Taraszkiewicz France 13 125 0.8× 159 1.3× 30 0.4× 97 1.4× 44 0.8× 25 356
Ananya Hooda United States 7 181 1.1× 110 0.9× 26 0.3× 111 1.6× 36 0.7× 12 328
Shinichi Tohyama Japan 12 240 1.5× 95 0.8× 113 1.4× 60 0.9× 19 0.4× 22 341
Marcello Ravani Italy 10 72 0.5× 172 1.5× 44 0.5× 61 0.9× 48 0.9× 27 296

Countries citing papers authored by Hirofumi Kawamata

Since Specialization
Citations

This map shows the geographic impact of Hirofumi Kawamata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Kawamata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Kawamata more than expected).

Fields of papers citing papers by Hirofumi Kawamata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirofumi Kawamata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Kawamata. The network helps show where Hirofumi Kawamata may publish in the future.

Co-authorship network of co-authors of Hirofumi Kawamata

This figure shows the co-authorship network connecting the top 25 collaborators of Hirofumi Kawamata. A scholar is included among the top collaborators of Hirofumi Kawamata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirofumi Kawamata. Hirofumi Kawamata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nishi, Masahiro, et al.. (2023). Association Between Patient Volume to Cardiologist, Process of Care, and Clinical Outcomes in Heart Failure. ESC Heart Failure. 10(4). 2262–2268. 4 indexed citations
3.
Kawamata, Hirofumi, Yusuke Hori, Yoshio Kohno, et al.. (2021). New risk factors for early- and late-onset cardiac rupture in ST-elevation myocardial infarction patients after primary percutaneous coronary intervention. Journal of Cardiology. 79(3). 400–407. 7 indexed citations
4.
Kawamata, Hirofumi, Michiyo Yamano, & Tatsuya Kawasaki. (2020). Duroziez’s Sign. Circulation Reports. 2(7). 380–381.
5.
Kawasaki, Tatsuya, et al.. (2019). Ventricular late potentials and myocardial fibrosis in hypertrophic cardiomyopathy. Journal of Electrocardiology. 58. 87–91. 4 indexed citations
6.
Kawamata, Hirofumi, Tatsuya Kawasaki, Ken‐ichi Kasai, et al.. (2017). Abnormal Blood Pressure Response to Exercise and Exercise Tolerance in Patients with Stable Heart Failure. Journal of Cardiac Failure. 23(10). S60–S60.
7.
Tani, Shigemasa, Toshio Kushiro, Atsuhiko Takahashi, et al.. (2016). Antihypertensive Efficacy of the Direct Renin Inhibitor Aliskiren as Add-on Therapy in Patients with Poorly Controlled Hypertension. Internal Medicine. 55(5). 427–435. 5 indexed citations
8.
Tani, Shigemasa, Takeo Anazawa, Hirofumi Kawamata, et al.. (2011). 低密度リポ蛋白質コレステロール/アポリポ蛋白質B比は冠動脈疾患を伴う及び伴わないスタチン治療患者で異なる有益な指標と考えられる 症例対照研究. International Heart Journal. 52(6). 343–347.
9.
Tani, Shigemasa, Takeo Anazawa, Hirofumi Kawamata, et al.. (2011). Low-density Lipoprotein Cholesterol/Apolipoprotein B Ratio May Be a Useful Index That Differs in Statin-Treated Patients With and Without Coronary Artery Disease. International Heart Journal. 52(6). 343–347. 19 indexed citations
10.
Tani, Shigemasa, Michiaki Matsumoto, Takeo Anazawa, et al.. (2011). Development of a model for prediction of coronary atherosclerotic regression: evaluation of high-density lipoprotein cholesterol level and peripheral blood monocyte count. Heart and Vessels. 27(2). 143–150. 25 indexed citations
11.
Tani, Shigemasa, Ken Nagao, Takeo Anazawa, et al.. (2010). Relation of Change in Apolipoprotein B/Apolipoprotein A-I Ratio to Coronary Plaque Regression After Pravastatin Treatment in Patients With Coronary Artery Disease. The American Journal of Cardiology. 105(2). 144–148. 14 indexed citations
12.
Tani, Shigemasa, Ken Nagao, Takeo Anazawa, et al.. (2009). Association of Leukocyte Subtype Counts With Coronary Atherosclerotic Regression Following Pravastatin Treatment. The American Journal of Cardiology. 104(4). 464–469. 31 indexed citations
13.
14.
Tani, Shigemasa, Ken Nagao, Takeo Anazawa, et al.. (2009). Association of Body Mass Index with Coronary Plaque Regression: 6-Month Prospective Study. Journal of Atherosclerosis and Thrombosis. 16(3). 275–282. 10 indexed citations
15.
Tani, Shigemasa, Ken Nagao, Takeo Anazawa, et al.. (2008). Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment. Atherosclerosis. 198(2). 360–365. 19 indexed citations
16.
Tani, Shigemasa, Ken Nagao, Takeo Anazawa, et al.. (2008). Treatment of Coronary Spastic Angina With a Statin in Addition to a Calcium Channel Blocker: A Pilot Study. Journal of Cardiovascular Pharmacology. 52(1). 28–34. 18 indexed citations
17.
Tani, Shigemasa, Ken Nagao, Takeo Anazawa, et al.. (2008). Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: Implication of acute coronary events. International Journal of Cardiology. 135(2). 202–206. 9 indexed citations
18.
19.
Tani, Shigemasa, Ikuyoshi Watanabe, Takeo Anazawa, et al.. (2005). Effect of Pravastatin on Malondialdehyde-Modified Low-Density Lipoprotein Levels and Coronary Plaque Regression as Determined by Three-Dimensional Intravascular Ultrasound. The American Journal of Cardiology. 96(8). 1089–1094. 50 indexed citations
20.
Matsumoto, Michiaki, Shigemasa Tani, Kimio Kikushima, et al.. (2002). Relationship Between Fractional Myocardial Flow Reserve and Myocardial Residual Viability in Recent Myocardial Infarction. Japanese Circulation Journal-english Edition. 66. 461. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michiaki Matsumoto Breakdown of academic impact, for papers by Takeo Anazawa Breakdown of academic impact, for papers by Sida Jia Breakdown of academic impact, for papers by Lin Jiang Breakdown of academic impact, for papers by E. de Groot Breakdown of academic impact, for papers by Shigeru Matsui Breakdown of academic impact, for papers by Dorota Taraszkiewicz Breakdown of academic impact, for papers by Ananya Hooda Breakdown of academic impact, for papers by Shinichi Tohyama Breakdown of academic impact, for papers by Marcello Ravani
Rankless by CCL
2026